Clinical trial

Telaprevir Open-Label Study in Co-Infected Patients

NCT01500616

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-06-01

PhasePHASE3

Study timeline

Study start (unknown)2012-06-01Date precision: month

Registry last updated2016-08-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hepatitis C, Chronicunresolved

Interventions

TelaprevirDRUG

Sponsors & collaborators

Janssen-Cilag International NVlead sponsor

Mapped research locations

LondonUnited Kingdom1 BerlinGermany1 BudapestHungary1 Saint PetersburgRussia1 BrusselsBelgium1 LeuvenBelgium1 HanoverGermany1 GhentBelgium1 GlasgowUnited Kingdom1 CologneGermany1 LisbonPortugal1 LiègeBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01500616 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.